Search Results
Found 2 results
510(k) Data Aggregation
(27 days)
SPECTRUM TURBO-JECT PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER SET
Spectrum Turbo-Ject® Peripherally Inserted Central Venous Catheter (PICC) Sets and Trays are intended for short- or long-term use for venous pressure monitoring, blood sampling, administration of drugs and fluids, and for use with power injectors for delivery of contrast in CT studies. The catheter is impregnated with the antimicrobials minocycline and rifampin to help provide protection against catheter-related bloodstream infections (CRBSIs). The Spectrum Turbo-Ject® PICC is indicated for multiple injections of contrast media through a power injector. The maximum pressure limit setting for Power Injectors used with the Turbo-Ject PICC may not exceed 325 psi and the flow rate may not exceed the maximum flow rate indicated.
The proposed Spectrum Turbo-Ject® PICCs are radiopaque polyurethane peripherally inserted central venous catheters for short- or long-term use, and can be inserted through a Peel-Away® introducer, or over-the-wire. The proposed devices are minimally tapered 4.0 Fr and 5.0 Fr single and double lumen catheters. The set components may include the PICC, obturator, Peel-Away® introducer, entry needles, wire guide, and other convenience components. The set is supplied sterile and is intended for one-time use.
The provided text describes a 510(k) summary for the Cook Medical Spectrum Turbo-Ject® Peripherally Inserted Central Venous Catheter Set. It outlines the device's intended use, comparison to predicate devices, and the testing conducted to demonstrate substantial equivalence.
Here's an analysis of the acceptance criteria and study information provided:
1. Table of Acceptance Criteria and Reported Device Performance
Test | Acceptance Criteria | Reported Device Performance |
---|---|---|
Tensile Testing | Peak load value > 10 N | Peak load value was greater than 10 N |
Dynamic Pressure Testing | Catheters do not fail during simulated use | Catheters did not fail during simulated use |
Static Failure Pressure Testing | Static failure pressure at or above the acceptance criterion | Static failure pressure was at or above the acceptance criterion |
Liquid Leakage Testing | Catheters do not leak liquid | Catheters did not leak liquid |
Air Leakage Testing | Catheters do not exhibit air leakage | Catheters did not exhibit air leakage |
Antimicrobial Testing | Minimum zone of inhibition of 15 mm | Catheters met the predetermined acceptance criteria |
Note: For "Static Failure Pressure Testing" and "Antimicrobial Testing", the specific numerical acceptance criteria (other than >15mm for antimicrobial, which is also stated as "predetermined") are not explicitly defined in the document, but the document states the device met them.
2. Sample Size and Data Provenance
The document does not explicitly state the sample sizes used for each specific test (e.g., number of catheters tested for tensile strength or leakage).
The data provenance is retrospective, as the submission is for modifications to previously cleared devices (K081690, K072625, K132334, K132885). The testing was conducted to demonstrate substantial equivalence to these predicate devices. The country of origin of the data is not specified, but the applicant address is in Bloomington, IN, USA.
3. Number of Experts and Qualifications
The document does not mention the involvement of experts to establish ground truth for a test set. The tests describe physical and performance characteristics of the device, which are typically evaluated through laboratory testing against predefined engineering specifications.
4. Adjudication Method
Not applicable. This type of submission (510k for a medical device) typically relies on laboratory testing and engineering specifications rather than expert adjudication of a test set, which is more common in diagnostic device or AI algorithm evaluations.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
No MRMC comparative effectiveness study was mentioned. The device is a "Peripherally Inserted Central Venous Catheter Set," a physical medical device, not a diagnostic imaging or AI-assisted system that would typically involve human readers.
6. Standalone (Algorithm Only) Performance Study
Not applicable. This is a physical medical device, not an algorithm or AI system.
7. Type of Ground Truth Used
The "ground truth" for this device's performance is based on engineering specifications and established criteria for medical device safety and effectiveness. For example:
- Tensile strength: Measured against a force (10 N).
- Leakage: Absence of liquid/air leakage.
- Pressure: Ability to withstand specified pressure (325 psi).
- Antimicrobial activity: Measured zone of inhibition (15 mm).
These are objective, quantitative measurements against predefined standards.
8. Sample Size for the Training Set
Not applicable. As a physical medical device, there is no "training set" in the context of machine learning or AI. The design and manufacturing process would involve internal validation and verification activities, but these are not referred to as training sets.
9. How the Ground Truth for the Training Set was Established
Not applicable, as there is no training set for this type of device. The specifications and acceptable performance limits are derived from industry standards (e.g., ISO 10555-1:1995), regulatory requirements, and the performance characteristics of predicate devices.
Ask a specific question about this device
(27 days)
SPECTRUM TURBO-JECT PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER
The Spectrum Turbo-JeCT PICC is indicated for short- or long-term use for venous pressure monitoring, blood sampling, administration of drugs and fluids, and for use with power injectors for delivery of contrast in CT studies. The catheter is impregnated with the antimicrobials minocycline and rifampin to help provide protection against catheterrelated bloodstream infections (CRBSIs). The Spectrum Turbo-JeCT PICC is indicated for multiple injections of contrast media through a power injector. The maximum pressure limit setting for power injectors used with the Spectrum Turbo-JeCT PICC may not exceed 325 psi and the flow rate may not exceed the maximum flow rate indicated.
The Spectrum Turbo-JeCT catheter is a radiopaque polyurethane peripherally inserted central venous catheter impregnated with antimicrobials and intended for short- or longterm use. The Spectrum Turbo-JeCT PICCs are 60 cm in length and available in 4 and 5 Fr single lumen and 5 Fr double lumen configurations.
The set components include an introducer needle, wire guide, locking Peel-Away introducer, 12cc syringe, drape, injection cap, catheter fixation device, tape measure, safety scalpel, and a hydrophilic-coated wire guide obturator for non-over-the-wire versions.
Here's an analysis of the provided text regarding the acceptance criteria and supporting studies for the Spectrum® Turbo-JeCT™ PICC device:
The provided text is a 510(k) summary for a medical device (PICC catheter), which primarily focuses on demonstrating substantial equivalence to predicate devices and lists the types of tests performed. It does not contain the detailed information required to populate all the requested fields, especially concerning the acceptance criteria for each test, specific numerical results against those criteria, or complex study designs like MRMC studies or ground truth establishment for AI systems. This is typical for a 510(k) summary, which is a high-level overview.
However, I can extract what is present and indicate where information is missing.
1. A table of acceptance criteria and the reported device performance
Acceptance Criteria (Implied/Explicit) | Reported Device Performance |
---|---|
PICC Catheter Performance (Explicit from Indications for Use) | |
Maximum Flow Rate: | |
4 Fr Single Lumen: Not to exceed 4 ml/sec (when using Omnipaque 300® at room temp and Medrad Stellant® CT injector) | Achieved (verified using Medrad Stellant® CT injector system) |
5 Fr Single Lumen: Not to exceed 7 ml/sec (when using Omnipaque 300® at room temp and Medrad Stellant® CT injector) | Achieved (verified using Medrad Stellant® CT injector system) |
5 Fr Double Lumen: Not to exceed 5 ml/sec (when using Omnipaque 300® at room temp and Medrad Stellant® CT injector) | Achieved (verified using Medrad Stellant® CT injector system) |
Injection Pressure Limit Setting: | |
Maximum pressure limit setting for power injectors not to exceed 325 psi. | 325 psi (This is the stated limit that the device is compatible with, implying it can withstand this or higher without failure, but no specific threshold for failure is given) |
General Device Performance (Implied from listing of tests) | |
Flow rate tests: Not explicitly stated, but assumed to meet the flow rates specified above. | "The Spectrum Turbo-JeCT PICC Catheter was subjected to the following tests to assure reliable design and performance under the specified testing parameters. ... The results of these tests provide reasonable assurance that the device has been designed and tested to assure conformance to the requirements for its use as a PICC catheter." Specific numerical results for each test are not detailed in the summary. |
Static burst failure pressure tests: Not explicitly stated, but implied to be sufficient for intended use (e.g., above 325 psi). | "The results of these tests provide reasonable assurance that the device has been designed and tested to assure conformance to the requirements for its use as a PICC catheter." |
Cyclic fatigue test: Not explicitly stated, but implied to show durability over time for intended use. | "The results of these tests provide reasonable assurance that the device has been designed and tested to assure conformance to the requirements for its use as a PICC catheter." |
Liquid leakage under pressure test: Not explicitly stated, but implied to demonstrate no leakage at intended pressures. | "The results of these tests provide reasonable assurance that the device has been designed and tested to assure conformance to the requirements for its use as a PICC catheter." |
Air leakage during aspiration test: Not explicitly stated, but implied to demonstrate no air leakage during aspiration. | "The results of these tests provide reasonable assurance that the device has been designed and tested to assure conformance to the requirements for its use as a PICC catheter." |
Tensile strength tests: Not explicitly stated, but implied to demonstrate sufficient strength to prevent breakage during use. | "The results of these tests provide reasonable assurance that the device has been designed and tested to assure conformance to the requirements for its use as a PICC catheter." |
Bond strength tests: Not explicitly stated, but implied to demonstrate strong and reliable bonds between components. | "The results of these tests provide reasonable assurance that the device has been designed and tested to assure conformance to the requirements for its use as a PICC catheter." |
Stiffness test: Not explicitly stated, but implied to meet requirements for insertion and flexibility. | "The results of these tests provide reasonable assurance that the device has been designed and tested to assure conformance to the requirements for its use as a PICC catheter." |
Shelf life tests: Not explicitly stated, but implied to demonstrate stability and integrity over its intended shelf life. | "The results of these tests provide reasonable assurance that the device has been designed and tested to assure conformance to the requirements for its use as a PICC catheter." |
Sterility tests: Not explicitly stated, but implied to meet sterility assurance level (SAL) requirements. | "The results of these tests provide reasonable assurance that the device has been designed and tested to assure conformance to the requirements for its use as a PICC catheter." |
Biocompatibility tests: Not explicitly stated, but implied to meet ISO 10993 requirements for medical devices in contact with blood. | "The results of these tests provide reasonable assurance that the device has been designed and tested to assure conformance to the requirements for its use as a PICC catheter." |
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
- Sample Size: Not specified in the provided summary for any of the tests.
- Data Provenance: Not specified, but likely from in-house laboratory testing (prospective, non-clinical). The equipment used for flow rates (Medrad Stellant® CT injector system) is a commercial product. The "Omnipaque 300®" contrast is a commercial product (Amersham Health, New Jersey).
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
- This question is not applicable. The device is a physical medical device (PICC catheter), not an AI/software device requiring expert interpretation of diagnostic images or data for ground truth establishment. The "ground truth" here is the physical performance of the catheter itself against engineering and physiological requirements.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
- This question is not applicable. Adjudication methods are typically used in clinical studies or studies involving human readers/interpreters to resolve discrepancies in diagnoses or assessments, not for physical performance testing of a catheter.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
- This question is not applicable. This device is a physical catheter, not an AI or software device intended for diagnostic interpretation or to assist human readers. Therefore, an MRMC study comparing human readers with and without AI assistance was not performed.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done
- This question is not applicable. This device is a physical catheter, not an algorithm or software. "Standalone performance" in this context would refer to the catheter's physical performance, as evaluated by the listed tests, independent of human operators (though human operators would be involved in setting up the tests). The tests performed are effectively "standalone" in this physical sense.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
- The "ground truth" for the physical performance tests would be defined by engineering specifications, regulatory standards, and established physiological requirements for central venous catheters. For example:
- Flow rate ground truth: The measured flow rate through the catheter compared against the specified maximum flow rate for safe and effective contrast delivery.
- Pressure ground truth: The pressure the catheter can withstand compared against the maximum allowed pressure for power injectors.
- Material integrity ground truth: Absence of leakage, breakage, or degradation under specified conditions.
- Biocompatibility ground truth: Absence of cytotoxic effects, sensitization, irritation, etc., as per ISO 10993 standards.
8. The sample size for the training set
- This question is not applicable. This device is a physical catheter, not an AI/machine learning model that requires a "training set" of data.
9. How the ground truth for the training set was established
- This question is not applicable for the same reason as #8.
Ask a specific question about this device
Page 1 of 1